Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Gerratana

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Clinical Breast Cancer|August 8, 2017
Determinants of Last-line Treatment in Metastatic Breast CancerMarika Cinausero, Lorenzo Gerratana, Elisa De Carlo, et al.
Melanoma Research|May 26, 2018
Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlationsDonatella Iacono, Marika Cinausero, Lorenzo Gerratana, et al.
Seminars in Cancer Biology|October 19, 2019
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cellsCarolina Reduzzi, Marta Vismara, Lorenzo Gerratana, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2018
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncologyClaudia Bozza, Lorenzo Gerratana, Debora Basile, et al.
Cancers|June 23, 2019
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to BedsideDebora Basile, Paola Di Nardo, Carla Corvaja, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancerElena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNAQiang Zhang, Zheng Cai, Lorenzo Gerratana, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Cancer Treatment Reviews|January 26, 2019
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Clinical Breast Cancer|August 8, 2017
Determinants of Last-line Treatment in Metastatic Breast CancerMarika Cinausero, Lorenzo Gerratana, Elisa De Carlo, et al.
Melanoma Research|May 26, 2018
Tumour-infiltrating lymphocytes, programmed death ligand 1 and cyclooxygenase-2 expression in skin melanoma of elderly patients: clinicopathological correlationsDonatella Iacono, Marika Cinausero, Lorenzo Gerratana, et al.
Seminars in Cancer Biology|October 19, 2019
The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cellsCarolina Reduzzi, Marta Vismara, Lorenzo Gerratana, et al.
Journal of Cancer Research and Clinical Oncology|July 26, 2018
Use and perception of complementary and alternative medicine among cancer patients: the CAMEO-PRO study : Complementary and alternative medicine in oncologyClaudia Bozza, Lorenzo Gerratana, Debora Basile, et al.
Cancers|June 23, 2019
Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to BedsideDebora Basile, Paola Di Nardo, Carla Corvaja, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 21, 2023
Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancerElena Peruzzi, Lorenzo Gerratana, Marcella Montico, et al.
Future Oncology (London, England)|March 10, 2018
MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiformeLorena Gurrieri, Elisa De Carlo, Lorenzo Gerratana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2024
Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNAQiang Zhang, Zheng Cai, Lorenzo Gerratana, et al.
Breast Cancer Research : BCR|December 6, 2019
Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancerAndrew A Davis, Qiang Zhang, Lorenzo Gerratana, et al.
Cancer Treatment Reviews|January 26, 2019
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?Giuseppe Buono, Lorenzo Gerratana, Michela Bulfoni, et al.
Pageof 13